reports
Axogen, Inc Reports First Quarter 2024 Financial Results
Axogen, Inc Reports First Quarter 2024 Financial Results ALACHUA, Fla. and TAMPA, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the first quarter ended March 31, 2024. First Quarter Financial Results First quarter revenue was $41.4 million, a 12.9% increase compared to the first quarter of 2023.In the first quarter of 2024, our gross margin increased to 78.8%, up from 77.7%, as reclassified* in the sam...
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™
Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™ ALACHUA, Fla. and TAMPA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, announces the first surgical implantations of its newest product, Avive+ Soft Tissue Matrix™. “We are excited to expand our offering in nerve protection with the introduction of this resorbable barrier to support the critical phases of healing for nerve injuries,” said Karen Zaderej, chairman, CEO, and president. “We are ...
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host C...
Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 ALACHUA, Fla. and TAMPA, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report first quarter 2024 financial results on Thursday, May 2, 2024, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the conferenc...
Assured Guaranty Ltd: 1 director
A director at Assured Guaranty Ltd sold 55,000 shares at 92.435USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
Camping World Holdings Inc: 1 director
A director at Camping World Holdings Inc sold 100,000 shares at 25.629USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Result...
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results ALACHUA, Fla. and TAMPA, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the fourth quarter and full-year ended December 31, 2023. Fourth Quarter 2023 Financial Results and Business Highlights Fourth quarter revenue was $42.9 million, an 18.7% increase compared to the fourth quarter of 2022.The Company estimates that revenues from ...
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Res...
Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024 ALACHUA, Fla. and TAMPA, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2023 fourth quarter and full-year financial results on Tuesday, March 5, 2024, before the market opens. Axogen management will host an investment-community conference call and webcast at 8 a.m. ET following the release. Investors interested in participating in the co...
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced making Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) in connection with the employment and appointment of John Manning to the position of Area Vice President of Sales. Mr. Manning will report to Doris Quackenbush, Vice President of Sales. In connection with the commencement of his employment on J...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
Continue Riding This Bull Market Higher Since early November 2023 we have laid out our bullish expectations for a year-end rally that we anticipated would continue into the early part of 2024. Here we are in the early part of 2024, and we see every reason to continue riding this bull market higher. Small- and Mid-Caps Resuming Uptrends. Looking at the big picture on the small-cap Russell 2000 (IWM) and the Vanguard Extended Market ETF (VXF, the entire U.S. market excluding the S&P 500), (1) th...
PGR PROGRESSIVE CORPORATION
MCY MERCURY GENERAL CORPORATION
ERIE ERIE INDEMNITY COMPANY CLASS A
CINF CINCINNATI FINANCIAL CORPORATION
CB CHUBB LIMITED
AXS AXIS CAPITAL HOLDINGS LIMITED
ALL ALLSTATE CORPORATION
FNF FIDELITY NATIONAL FINANCIAL INC. - FNF GROUP
AGO ASSURED GUARANTY LTD.
UFCS UNITED FIRE GROUP INC.
SAFT SAFETY INSURANCE GROUP INC.
BRK.B BERKSHIRE HATHAWAY INC. CLASS B
CNA CNA FINANCIAL CORPORATION
THG HANOVER INSURANCE GROUP INC.
WRB W. R. BERKLEY CORPORATION
AMBC AMBAC FINANCIAL GROUP INC.
KNSL KINSALE CAPITAL GROUP INC.
CNNE CANNAE HOLDINGS
GSHD GOOSEHEAD INSURANCE
KFS KINGSWAY FINANCIAL SERVICES
STC SANGOMA TECHNOLOGIES CORP.
SKWD SKYWARD SPECIALTY INS GROUP INC
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospec...
Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap REPOSE® met its primary endpoint of non-inferiority between the pain visual analog scale outcomes for neurectomy with Axoguard Nerve Cap® vs. standard-of-care neurectomy at Month 12. Axoguard Nerve Cap demonstrated statistical superiority vs. standard-of-care neurectomy in the reduction of total pain reported by participants over the course of follow-up. ALACHUA, Fla. and TAMPA, Fla., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
TAST CARROLS RESTAURANT GROUP INC
SWN SOUTHWESTERN ENERGY COMPANY
FHN FIRST HORIZON CORPORATION
D8Q BANCO LATINOAMERICANO DE COMERCIO EXTERIOR S.A. CLASS E
AXGN AXOGEN INC.
ARWR ARROWHEAD PHARMACEUTICALS INC.
APEI AMERICAN PUBLIC EDUCATION
SYF SYNCHRONY FINANCIAL
TATT TAT TECHNOLOGIES LTD.
LNC LINCOLN NATIONAL CORPORATION
NRP NATURAL RESOURCE PARTNERS L.P.
MLP MAUI LAND & PINEAPPLE CO. INC.
HBB HAMILTON BEACH BRANDS HOLDING COMPANY
AGS PLAYAGS INC
SSNT SILVERSUN TECHNOLOGIES
ELAN ELANCO ANIMAL HEALTH INC.
YMAB Y-MABS THERAPEUTICS
INMB INMUNE BIO
LEVI LEVI STRAUSS & CO. CLASS A
HOV HOVNANIAN ENTERPRISES INC. CLASS A
IGMS IGM BIOSCIENCES
PNTG PENNANT GROUP
KRUS KURA SUSHI USA
ETRN EQUITRANS MIDSTREAM CORP.
STTK SHATTUCK LABS
IMVT IMMUNOVANT
VTRS VIATRIS INC.
CBRG CHAIN BRIDGE I
LUXH LUXURBAN HOTELS INC
NGNE NEUROGENE INC
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Fu...
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023 ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2023 revenue. Preliminary Unaudited Fourth Quarter and Year-End Performance and Business Highlights Fourth quarter revenue is expected to be approximately $42.7 million, which represents an 18% increase over the fourth-quarter of 2022 driven by...
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej...
Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025 ALACHUA and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that President and Chief Executive Officer (CEO) Karen Zaderej plans to retire from the Company by January 2025. The Company’s Board of Directors will retain an executive recruitment firm to manage a search for her successor. When a new CEO is in place, Ms. Zaderej will step ...
Axogen Announces Promotions on Research and Development Team
Axogen Announces Promotions on Research and Development Team Company Also Announces Departure of Angelo Scopelianos, Ph.D. ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the promotions of three research and development team members. The promotions are: Erick DeVinney to Chief Innovation Officer Mr. DeVinney joined Axogen in April of 2007 as Director of Clinical Research. During his tenure, he has held positions of progr...
Axogen Announces Transition of Finance Team Leadership
Axogen Announces Transition of Finance Team Leadership Nir Naor Appointed CFO to Replace Peter Mariani as Company Aligns Executive Team with Financial Management Needs for Next Phase of Growth ALACHUA, Fla. and TAMPA, Fla., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Mr. Nir Naor as Chief Financial Officer, effective immediately. A senior finance executive with more than 20 years of experience primarily in the life sciences indust...
- Jonathan Moreland
ITW ILLINOIS TOOL WORKS INC.
XRAY DENTSPLY SIRONA INC.
TNDM TANDEM DIABETES CARE INC
TCBI TEXAS CAPITAL BANCSHARES INC.
STAA STAAR SURGICAL CO.
SHBI SHORE BANCSHARES INC.
MRCY MERCURY SYSTEMS INC.
LMAT LEMAITRE VASCULAR INC.
KMPR KEMPER CORPORATION
GABC GERMAN AMERICAN BANCORP
BMY BRISTOL-MYERS SQUIBB COMPANY
AMRC AMERESCO
FMC FMC CORPORATION
HTLD HEARTLAND EXPRESS INC.
OESX ORION ENERGY SYSTEMS INC.
KYN KAYNE ANDERSON MLP INVESTMENT CO.
CTHR CHARLES & COLVARD LTD.
PLSE PULSE BIOSCIENCES
VRNA VERONA PHARMA ADS
LAZY LAZYDAYS HOLDINGS
SPB SPECTRUM BRANDS HOLDINGS INC.
AXR AMREP
ATRI ATRION CORPORATION
ITRM ITERUM THERAPEUTICS
ZM ZOOM VIDEO COMMUNICATIONS
ATEX INC.
KSM ANTERIX
PTON DWS STRATEGIC MUNICIPAL INCOME TRUST
GDRX PELOTON INTERACTIVE
ONDS INC.
AGL GOODRX HOLDINGS
AUID INC.
AUGX ONDAS HOLDINGS
VWE AGILON HEALTH
VTRS INC.
SGHT IPSIDY INC.
VPV AUGMEDIX
CYT INC.
FTK VINTAGE WINE ESTATES INC
CEV VIATRIS INC
SEEL SIGHT SCIENCES INC
INVESCO PA VALUE MUNI INC TST
CYTEIR THERAPEUTICS INC
FLOTEK INDUSTRIES INC.
EATON VANCE CALIFORNIA MUN INC TRST
SENTINEL ELECTRONICS
- Jonathan Moreland
ITW ILLINOIS TOOL WORKS INC.
DKS DICK'S SPORTING GOODS INC.
CVV CVD EQUIPMENT
PLSE PULSE BIOSCIENCES
NQP NUVEEN PENNSYLVANIA INVESTMENT QUALITY MUNICIPAL FUND INC.
NXJ NUVEEN NEW JERSEY DIVIDEND ADVANTAGE MUNICIPAL FUND
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ATRI ATRION CORPORATION
ZM ZOOM VIDEO COMMUNICATIONS
ATEX INC.
KSM ANTERIX
VTN DWS STRATEGIC MUNICIPAL INCOME TRUST
ENX INVESCO TRUST FOR INVESTMENT G
PUBM EATON VANCE NEW YORK MUNICIPAL BOND FUND
SGHT PUBMATIC
EMO SIGHT SCIENCES INC
VPV CLEARBRIDGE ENERGY MLP OPPORTUNITY FUND INC.
CEV INVESCO PA VALUE MUNI INC TST
SEEL EATON VANCE CALIFORNIA MUN INC TRST
SENTINEL ELECTRONICS
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ALACHUA and TAMPA, Fla., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced making Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) in connection with the employment and appointment of Harold D. Tamayo as Vice President of Finance and Investor Relations. Mr. Tamayo will report to Peter J. Mariani, Executive Vice President and Chief Financial Officer, and will be responsible for Fina...
Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcar...
Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference ALACHUA and TAMPA, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, Chairman, Chief Executive Officer, and President, will present at the Piper Sandler 35th Annual Healthcare Conference in New York, NY, on Thursday, November 30, 2023, at 8:50 a.m. E.T. Webcast events can be accessed live through the page at For those not available to listen to th...
Axogen, Inc. Reports 2023 Third Quarter Financial Results
Axogen, Inc. Reports 2023 Third Quarter Financial Results ALACHUA, Fla. and TAMPA, Fla., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today reported financial results and business highlights for the third quarter ended September 30, 2023. Third Quarter Financial Results Revenue was $41.3 million during the third quarter, an increase of approximately 12% over the third quarter of 2022.The Company estimates that revenues from emergent trauma procedures represented app...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.